至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Foot-and-Mouth Disease (FMD) Virus 3C Protease Mutant L127P: Implications for FMD Vaccine Development.

J. Virol.. 2017; 
PucketteMichael,ClarkBenjamin A,SmithJustin D,TurecekTraci,MartelErica,GabbertLindsay,PisanoMelia,HurtleWilliam,PachecoJuan M,BarreraJosé,NeilanJohn G,Rasmusse
Products/Services Used Details Operation
Plasmid DNA Preparation The pTarget GLuc -Δ1D2A -HIV -3C(C142T) plasmid was constructed based on the previously 283 described pTarget GLuc -Δ1D2A plasmid, (22 ), with the sequence for HIV -3C(C142T) derived 284 from previous publication ( 9 ), synthesized by GenScript, and inserted using XmaI and NotI 285 restriction enzymes as described above. Get A Quote

摘要

The foot-and-mouth disease virus (FMDV) afflicts livestock in more than 80 countries, limiting food production and global trade. Production of foot-and-mouth disease (FMD) vaccines requires cytosolic expression of the FMDV 3C protease to cleave the P1 polyprotein into mature capsid proteins, but the FMDV 3C protease is toxic to host cells. To identify less-toxic isoforms of the FMDV 3C protease, we screened 3C mutants for increased transgene output in comparison to wild-type 3C using a luciferase reporter system. The novel point mutation 3C(L127P) increased yields of recombinant FMDV subunit proteins in mammalian and bacterial cells expressing P1-3C transgenes and retained the ability to process P1 polyp... More

关键词

3C protease,Escherichia coli,Gaussia luciferase,StopGo translation,VLP,adenoviruses,foot-and-mouth disease virus,in vivo,in vivo expression technology,translational interrupter,vaccines,virus-like parti